ReviewFrontiers in pharmacology2024

Exploiting gender-based biomarkers and drug targets: advancing personalized therapeutic strategies in hepatocellular carcinoma.

Lanqian Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.